Nano-Check Influenza+COVID-19 Dual Test

The Nano-Check™ Influenza+COVID-19 Dual Test is a lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of influenza A, and influenza B…

Registry build 21.09.26

The Nano-Check™ Influenza+COVID-19 Dual Test is a lateral flow immunochromatographic assay intended for the qualitative detection and differentiation of influenza A, and influenza B nucleoprotein antigens and SARS-CoV-2 nucleocapsid antigen directly in anterior nasal swab (ANS) samples from individuals with signs and symptoms of respiratory tract infection. Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar. All negative results are presumptive and should be confirmed with a molecular assay, if necessary, for patient management. Negative results do not rule out infection with influenza or SARS-CoV-2 and should not be used as the sole basis for treatment or patient management decisions. Positive results do not rule out bacterial infection or co-infection with other viruses.

4manufacturers in China registered for this device type
1catalogue number
1510(k) clearance

Who Else Makes It

Concentrated in Zhejiang (1), Guangdong (1), Tianjin (1). 3 of them are registered as contract manufacturers, able to build to a buyer’s own specification.

Chinese manufacturers registered for FDA product code SCA
Manufacturer City Province Registered as Device types
Zhejiang Orient Gene Biotech Huzhou Zhejiang Contract manufacturer 86
Guangzhou Wondfo Biotech Co., Ltd. Guangzhou Guangdong Contract manufacturer 44
Biohit Healthcare (Hefei) Co., Ltd. Hefei Anhui Contract manufacturer 4
Andon Health Co., Ltd. Tianjin Tianjin Contract manufacturer 22

Record

Regulatory record for Nano-Check Influenza+COVID-19 Dual Test
Listed by Nano-Ditech Corporation, United States
FDA product code SCA
Device type Multi-Analyte Respiratory Virus Antigen Detection Test
Device class Class 2
Regulation 21 CFR 866.3987
Establishment Repacker / relabeller, Manufacturer, Exporter
Record published 2026-01-16

Specifications

Specifications
MRI safety Labeling does not contain MRI Safety Information
Single use Yes
Prescription Prescription only
Supplied as a kit Yes
Label carries lot or batch number, expiry date, manufacturing date
Storage Handling environment temperature 2 to 30 °C

Catalogue Numbers

Catalogue numbers for Nano-Check Influenza+COVID-19 Dual Test
Catalogue number Size Per pack Status
MD8154 25 In distribution

Same Product Code

Other products under the same FDA product code
Product Sold by Catalogue numbers
WELLlife™ Wondfo USA Co., Ltd. 22
BinaxNOW COVID-19/Flu A&B Combo Self Test Alere Scarborough, Inc. 12
iHealth iHealth Labs, Inc. 7
QuickFinder™ COVID-19/Flu Antigen Self Test Osang Healthcare Co., Ltd. 4
Rapid Response Btnx Inc. 3
Healgen Healgen Scientific Limited Liability Company 3
HealthConfirm Confirm Biosciences LLC 3
CareSuperb COVID-19/FluA&B Antigen Combo HomeTest Access Bio, Inc. 3
McKesson Mckesson Medical-Surgical Inc. 3
CVS Health Woonsocket Prescription Center, Incorporated 2
COVID/Flu A&B RespiraDXTM Rapid Self-Test Inbios International, Inc. 2
GenaCheck® COVID-19/Flu A&B Rapid Self-Test Genabio Diagnostics Inc 2

Showing 12 of 28. All products under Multi-Analyte Respiratory Virus Antigen Detection Test

510(K) Clearances

FDA 510(k) clearances naming this product code
Clearance Decision date
K243561 2025-06-17

Source: U.S. FDA establishment registration and device listing records, public domain. Restructured for clarity and searchability. Not affiliated with or endorsed by the FDA. Records are records: nothing here is an offer of sale.

Where China Actually Supplies

Every device page names the company that lists it and the factories registered to make the same thing. These are the sections with the most of them.

5,100manufacturers registered in China
2,581device types they are registered for
340,248device records, each naming its maker
31provinces with a registered manufacturer